Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase

Journal of Lipid Research

Volumn 44, Issue 9, 2003, Pages 1652-1659

  Fajas, Lluis ^a,c   Miard, Stéphanie ^b   Briggs, Michael R ^b   Auwerx, Johan ^a  

^a CNRS   (France)

^b PFIZER INC   (United States)

^c INSERM   (France)

Author keywords

Cell cycle; Insulin resistance; Obesity; Peroxisome proliferator activated receptor

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; 4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2; PROSTAGLANDIN J2; SC 58560; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CLONOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0141571073     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300248-JLR200     Document Type: Article

References (34)

1. Coleman, R. A., W. L. Smith, and S. Narumiya. 1994. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229.
2. Marnett, L. J., and A. S. Kalgutkar. 1999. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol. Sci. 20: 465-469.
3. Dubois, R. N., S. B. Abramson, L. Crofford, R. A. Gupta, L. S. Simon, L. B. Van De Putte, and P. E. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12: 1063-1073.
4. Fajas, L., J. C. Fruchart, and J. Auwerx. 1998. Transcriptional control of adipogenesis. Curr. Opin. Cell Biol. 10: 165-173.
5. Reusch, J. E., L. A. Colton, and D. J. Klemm. 2000. CREB activation induces adipogenesis in 3T3-LI cells. Mol. Cell. Biol. 20: 1008-1020.
6. Aubert, J., P. Saint-Marc, N. Belmonte, C. Dani, R. Negrel, and G. Ailhaud. 2000. Prostacyclin IP receptor up-regulates the early expression of C/EBPbeta and C/EBPdelta in preadipose cells. Mol. Cell. Endocrinol. 160: 149-156.
7. Fajas, L., R. L. Landsberg, Y. Huss-Garcia, C. Sardet, J. A. Lees, and J. Auwerx. 2002. E2Fs regulate adipogenesis. Dev. Cell. 3: 39-49.
8. Reichert, M., and D. Eick. 1999. Analysis of cell cycle arrest in adipocyte differentiation. Oncogene. 18: 459-466.
9. Richelsen, B. 1991. Prostaglandins in adipose tissue-with special reference to triglyceride metabolism. Dan. Med. Bull. 38: 228-244.
10. Shillabeer, G., V. Kumar, E. Tibbo, and D. C. Lau. 1998. Arachidonic acid metabolites of the lipoxygenase as well as the cyclooxygenase pathway may be involved in regulating preadipocyte differentiation. Metabolism. 47: 461-466.
11. Lepak, N. M., and G. Serrero. 1993. Inhibition of adipose differentiation by 9 alpha, 11 beta-prostaglandin F2 alpha. Prostaglandins. 46: 511-517.
12. Debril, M. B., J. P. Renaud, L. Fajas, and J. Auwerx. 2001. The pleiotropic functions of peroxisome proliferator-activated receptor gamma. J. Mol. Med. 79: 30-47.
13. Fajas, L., D. Auboeuf, E. Raspe, K. Schoonjans, A. M. Lefebvre, R. Saladin, J. Najib, M. Laville, J. C. Fruchart, S. Deeb, A. Vidal-Puig, J. Flier, M. R. Briggs, B. Staels, H. Vidal, and J. Auwerx. 1997. Organization, promoter analysis and expression of the human PPARγ gene. J. Biol. Chem. 272: 18779-18789.
14. Rocchi, S., F. Picard, J. Vamecq, L. Gelman, N. Potier, D. Zeyer, L. Dubuquoy, P. Bac, M. F. Champy, K. D. Plunket, L. M. Leesnitzer, S. G. Blanchard, P. Desreumaux, D. Moras, J. P. Renaud, and J. Auwerx. 2001. A unique PPRgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell. 8: 737-747.
15. Sheng, G. G., J. Shao, H. Sheng, E. B. Hooton, P. C. Isakson, J. D. Morrow, R. J. Coffey, Jr., R. N. DuBois, and R. D. Beauchamp. 1997. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology. 113: 1883-1891.
16. Sheng, H., J. Shao, S. C. Kirkland, P. Isakson, R. J. Coffey, J. Morrow, R. D. Beauchamp, and R. N. DuBois. 1997. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99: 2254-2259.
17. Negrel, R., D. Gaillard, and G. Ailhaud. 1989. Prostacyclin as a potent effector of adipose-cell differentiation. Biochem. J. 257: 399-405.
18. Gaillard, D., R. Negrel, M. Lagarde, and G. Ailhaud. 1989. Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem. J. 257: 389-397.
19. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270: 12953-12956.
20. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-Δ12,14 prostaglandin J2 is a ligand for the adipocyte determination factor PPARη. Cell. 83: 803-812.
21. Ujihara, M., Y. Urade, N. Eguchi, H. Hayashi, K. Ikai, and O. Hayaishi. 1988. Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260: 521-531.
22. Belmonte, N., B. W. Phillips, F. Massiera, P. Villageois, B. Wdziekonski, P. Saint-Marc, J. Nichols, J. Aubert, K. Saeki, A. Yuo, S. Narumiya, G. Ailhaud, and C. Dani. 2001. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes. Mol. Endocrinol. 15: 2037-2049.
23. Gupta, R. A., J. Tan, W. F. Krause, M. W. Geraci, T. M. Willson, S. K. Dey, and R. N. DuBois. 2000. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl. Acad. Sci. USA. 97: 13275-13280.
24. Hansen, J. B., H. Zhang, T. H. Rasmussen, R. K. Petersen, E. N. Flindt, and K. Kristiansen. 2001. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J. Biol. Chem. 276: 3175-3182.
25. Jehl-Pietri, C., C. Bastie, I. Gillot, S. Luquet, and P. A. Grimaldi. 2000. Peroxisome-proliferator-activated receptor delta mediates the effects of long-chain fatty acids on post-confluent cell proliferation. Biochem. J. 350: 93-98.
26. He, T. C., T. A. Chan, B. Vogelstein, and K. W. Kinzler. 1999. PPAR-delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99: 335-345.
27. Park, B. H., B. Vogelstein, and K. W. Kinzler. 2001. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci. USA. 98: 2598-2603.
28. Rudnick, D. A., D. H. Perlmutter, and L. J. Muglia. 2001. Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc. Natl. Acad. Sci. USA. 98: 8885-8890.
29. Kimura, M., S. Osumi, and M. Ogihara. 2001. Prostaglandin E(2) (EP(1)) receptor agonist-induced DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: the involvement of TGF-alpha. Endocrinology. 142: 4428-4440.
30. Borglum, J. D., S. B. Pedersen, G. Ailhaud, R. Negrel, and B. Richelsen. 1999. Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation. Prostaglandins Other Lipid Mediat. 57: 305-317.
31. Reginato, M. J., S. L. Krakow, S. T. Bailey, and M. A. Lazar. 1998. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 273: 1855-1858.
32. Yan, H., A. Kermouni, M. Abdel-Hafez, and D. C. Lau. 2003. Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J. Lipid Res. 44: 424-429.
33. Howe, L. R., K. Subbaramaiah, A. M. Brown, and A. J. Dannenberg. 2001. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr. Relat. Cancer. 8: 97-114.
34. Das, U. N. 2001. Is obesity an inflammatory condition? Nutrition. 17:953-966.